Skye Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-2.9M | $64.8K |
| FY2017 | — | $-3.6M | $260.0K |
| FY2018 | — | $-15.6M | $1.9M |
| FY2019 | — | $548.1K | $1.8M |
| FY2020 | — | $450.8K | $2.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-2.9M | $64.8K |
| FY2017 | — | $-3.6M | $260.0K |
| FY2018 | — | $-15.6M | $1.9M |
| FY2019 | — | $548.1K | $1.8M |
| FY2020 | — | $450.8K | $2.5M |